Slitrk5 antibody was raised against a 14 amino acid peptide from near the center of human Slitrk5.
Conjugate
Unconjugated
Target
Alternative Names
SLITRK5; SLIT and NTRK-like family, member 5; LRRC11; bA364G4.2; SLIT and NTRK-like protein 5; slit and trk like gene 5; leucine rich repeat containing 11; leucine-rich repeat-containing protein 11
Members of the SLITRK family, such as SLITRK5, are integral membrane proteins with 2 N-terminal leucine-rich repeat (LRR) domains similar to those of SLIT proteins (see SLIT1; MIM 603742). Most SLITRKs, including SLITRK5, also have C-terminal regions that share homology with neurotrophin receptors (see NTRK1; MIM 191315). SLITRKs are expressed predominantly in neural tissues and have neurite-modulating activity (Aruga et al., 2003 [PubMed 14557068]).[supplied by OMIM, Mar 2008]
Custom Antibody Labeling
We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody. Learn More
Citations
Have you cited DPAB-L21154 in a publication? Let us know and earn a reward for your research.
Mah, AK; et al. SLITRK5, a protein that links striatal deficits to OCD-like behaviours in mice. CLINICAL GENETICS 78:350-352(2010).
Pallanti, S; Hollander, E; et al. Pharmacological, experimental therapeutic, and transcranial magnetic stimulation treatments for compulsivity and impulsivity. CNS SPECTRUMS 19:50-61(2014).
Payment methods we support:
Invoice / Purchase Order
Credit card
My Review for Anti-SLITRK5 polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.